Article
MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.
Annals of hematology - 1 May 2006
Seidemann Kathrin, Book Marion, Zimmermann Martin, Meyer Ulrike, Welte Karl, Stanulla Martin, Reiter Alfred
Abstract excerpt
We analyzed the relationship of genetic variation within the methylenetetrahydrofolate reductase gene (MTHFR 677 C-->T) with clinical characteristics, outcome, and therapy-related toxicity in pediatric non-Hodgkin's lymphoma (NHL) in our multicenter trial NHL-BFM 95. In this trial, high-dose methotrexate (MTX) infusion regimens were randomized (4- vs 24-h infusion) in patients with B-cell lymphoma; MTX was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
